Skip to main content

Table 3 Clinical characteristics of individuals in the VITD group

From: Short-term effects of high-dose oral vitamin D3 in critically ill vitamin D deficient patients: a randomized, double-blind, placebo-controlled pilot study

          25(OH)D levels
  Gender Age BMI Diagnosis Gastrointestinal function Application VP MV Day 0 Day 3 Day 7
02 female 83 33.2 Pneumonia normal FT yes yes 13.7 64.2 59.4
05 male 72 30.1 Heart failure, renal transplant normal FT yes yes 12.2 33.1 34.8
06 male 77 21.1 Myelodysplastic syndrome, sepsis normal O no no 10.1 36.5 -
08 male 84 23.1 Pneumonia normal FT yes yes 16.0 50.6 63.4
11 male 55 36.6 Wegener's granulomatosis, renal failure normal FT no yes 10.8 26.9 29.8
14 female 45 21.7 CPR (near-drowning) hypoxic gastrointestinal dysfunction FT yes yes 9.7 8.3 10.3
15 male 78 27.0 Seizures normal FT no yes 10.1 63.5 -
16 male 58 27.4 H1N1 influenza, renal transplant normal O no no 13.7 30.5 50.3
18 male 47 27.5 H1N1 influenza, renal transplant normal FT yes yes 15.1 42.9 29.3
22 female 51 24.8 CPR (ventricular fibrillation) normal FT yes yes 12.8 36.6 43.6
25 male 46 17.3 Allogeneic stem cell transplantation for chronic myeloid leukemia sclerodermiform gastrointestinal graft-versus-host disease FT yes yes 15.4 24.5 22.1
26 male 37 54.6 Pneumonia normal FT yes yes 12.0 33.0 38.8
  1. 25(OH)D, 25-hydroxyvitamin D, BMI, body mass index; CPR, cardiopulmonary resuscitation; FT, feeding tube; MV, mechanical ventilation; O, oral; VITD, vitamin D; VP, vasopressor.